🇺🇸 FDA
Patent

US 8273741

Imidazo-pyridazinyl compounds and uses thereof

granted A61PA61P11/06A61P13/12

Quick answer

US patent 8273741 (Imidazo-pyridazinyl compounds and uses thereof) held by Takeda Pharmaceutical Company Limited expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P11/06, A61P13/12, A61P15/08, A61P17/06